Form 4 Tracker
Immunovant, Inc.
IMVT

31 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 26, 2026Jun 26 11:46 PMMelanie GloriaChief Operating Officer
Sale
17,714$38.31$678.6K224,393(D)

View →

Jun 26, 2026Jun 26 11:45 PMJay S StoutChief Technology Officer
Sale
40,000$38.31$1.5M211,685(D)

View →

Jun 26, 2026Jun 26 11:45 PMTuyl Christopher VanChief Legal Officer
Sale
17,824$38.31$682.9K180,597(D)

View →

Jun 26, 2026Jun 26 11:44 PMTiago GiraoChief Financial Officer
Sale
10,000$38.46$384.6K247,596(D)

View →

Jun 26, 2026Jun 26 11:43 PMAtul PandeDirector
Sale
1,500$38.01$57.0K116,731(D)

View →

Jun 26, 2026Jun 26 8:25 PMJAY S STOUT
Proposed Sale
40,000$38.30$1.5M

View →

Jun 26, 2026Jun 26 8:22 PMCHRIS ADAIR VAN TUYL
Proposed Sale
17,824$38.31$682.8K

View →

Jun 26, 2026Jun 26 8:20 PMMELANIE GLORIA
Proposed Sale
17,714$38.31$678.6K

View →

Jun 26, 2026Jun 26 8:18 PMTIAGO GIRAO
Proposed Sale
10,000$38.46$384.6K

View →

Jun 18, 2026Jun 22 8:02 PMTuyl Christopher VanChief Legal Officer
Sale
2,634$35.39$93.2K180,597(D)

View →

Jun 15, 2026Jun 16 8:03 PMAtul PandeDirector
Sale
1,500$34.02$51.0K116,731(D)

View →

Jun 15, 2026Jun 15 8:35 PMAtul Pande
Proposed Sale
6,000$33.62$201.7K

View →

May 28, 2026May 29 8:04 PMAndrew J. FromkinDirector
Sale
221,951$33.51$7.4M74,382(D)

View →

May 28, 2026May 28 8:12 PMANDREW J FROMKIN
Proposed Sale
221,951$33.52$7.4M

View →

May 20, 2026May 22 8:03 PMMelanie GloriaChief Operating Officer
Sale
3,115$32.45$101.1K242,107(D)

View →

May 20, 2026May 21 1:22 AMAtul PandeDirector
Sale
6,000$32.00$192.0K116,731(D)

View →

May 20, 2026May 20 8:37 PMAtul Pande
Proposed Sale
6,000$26.29$157.7K

View →

May 1, 2026May 1 10:40 PMRobert Graham SusmanDirector
Sale
2,502$27.17$68.0K36,394(D)

View →

May 1, 2026May 1 8:46 PMROBERT G SUSMAN
Proposed Sale
2,502$27.15$67.9K

View →

Apr 23, 2026Apr 24 8:07 PMTiago GiraoChief Financial Officer
Sale
25,760$29.62$763.0K247,596(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 26, 2026Jun 26 11:45 PMTuyl Christopher VanChief Legal Officer
Option Exercise
17,824$15.2053,707(D)

View →

Jun 26, 2026Jun 26 11:44 PMTiago GiraoChief Financial Officer
Option Exercise
10,000$15.90283,505(D)

View →

Jun 26, 2026Jun 26 11:43 PMAtul PandeDirector
Option Exercise
1,500$8.4368,181(D)

View →

Jun 15, 2026Jun 16 8:03 PMAtul PandeDirector
Option Exercise
1,500$8.4369,681(D)

View →

May 28, 2026May 29 8:04 PMAndrew J. FromkinDirector
Option Exercise
196,601$14.700(D)

View →

May 20, 2026May 21 1:22 AMAtul PandeDirector
Option Exercise
6,000$8.43270,252(D)

View →

Apr 7, 2026Apr 9 8:31 PMFrank TortiDirector
Grant/Award
88,325$24.6188,325(D)

View →

Apr 7, 2026Apr 9 8:28 PMAndrew J. FromkinDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:26 PMDouglas J. HughesDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:25 PMAtul PandeDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:23 PMJake BauerDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:22 PMRobert Graham SusmanDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:20 PMMelanie GloriaChief Operating Officer
Grant/Award
121,063$24.61121,063(D)

View →

Apr 7, 2026Apr 9 8:19 PMJay S StoutChief Technology Officer
Grant/Award
96,851$24.6196,851(D)

View →

Apr 7, 2026Apr 9 8:17 PMTuyl Christopher VanChief Legal Officer
Grant/Award
59,820$24.6159,820(D)

View →

Apr 7, 2026Apr 9 8:13 PMEric VenkerDirector, Chief Executive Officer
Grant/Award
336,043$24.61336,043(D)

View →

Apr 7, 2026Apr 9 8:10 PMTiago GiraoChief Financial Officer
Grant/Award
94,002$24.6194,002(D)

View →

Apr 1, 2026Apr 3 8:33 PMEric VenkerDirector, Chief Executive Officer
Option Exercise
368,7501,106,250(D)

View →